Eight years cancer-free after treatment for a rare ovarian Brenner tumor

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: High Ki-67

At 8-year follow-up, surveillance showed no clinical or radiologic evidence of disease.

PubMed CentralRead more →

Stage IB anorectal melanoma: abdominoperineal resection and 6-month no recurrence

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: Anorectal melanoma markers positive for HMB45, S-100, Melan-A

At 6-month follow-up after abdominoperineal resection with sigmoid colostomy, digital rectal examination, sigmoidoscopy, and CT showed no evidence of recurrence.

PubMed CentralRead more →

No recurrence 7 months after surgery for a rare lung epithelial-myoepithelial cancer

Patient Info: Anonymized, Male, 60s | Stage I

At 7-month follow-up, there was no sign of recurrence after surgery.

PubMed CentralRead more →

Stage I luminal A invasive ductal breast cancer with post-treatment cognitive symptoms

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: ER 100% positive; PR 95% positive; HER2 score 0 / HER2-negative; Ki-67 10%; P63 negative

As of April 2026, the case focused on survivorship after Stage I luminal A breast cancer treatment, with cognitive complaints after chemotherapy and improved MoCA and depression scores after 12 sessions of tDCS; brain metastases had been ruled out.

PubMed CentralRead more →

Synchronous Stage IA lung adenocarcinoma and grade 4 glioblastoma: lung nodule regressed during brain-cancer therapy

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: Lung molecular biomarkers not reported; glioblastoma biomarker details not summarized in library fields

The Stage IA lung adenocarcinoma was monitored without lung-directed therapy and decreased from 18 mm to 9 mm while CNS-directed glioblastoma treatment continued; she remained alive with no lung cancer progression.

PubMed CentralRead more →

Stage I EGFR Lung Cancer: Shira's Survivor Story

Patient Info: Shira, Female | Stage I

Biomarkers: EGFR exon 20 insertion

Shira had Stage IB lung cancer detected early through imaging and treated with surgery alone. Her tumor was later categorized as low risk of recurrence, and she described herself as cancer-free as of February 2026.

The Patient StoryRead more →

Stage I Colorectal Cancer: Timothy's Survivor Story

Patient Info: Timothy Beckner, Male, 40s | Stage I

As of February 2026, Timothy was cancer-free after laparoscopic surgery for Stage I cecum/right-sided colon cancer and was moving into surveillance colonoscopy follow-up.

Cleveland ClinicRead more →

Prior Stage IA lung adenocarcinoma with fungal airway disease mimicking recurrence

Patient Info: Anonymized, Female, 70+ | Stage I

Her prior Stage IA lung adenocarcinoma was surgically treated without adjuvant therapy, and later pulmonary lesions were attributed to allergic bronchopulmonary mycosis rather than cancer recurrence; symptoms and imaging improved after antifungal and inhaled therapy.

PubMed CentralRead more →

Stage I Lung Cancer: Taylor's Survivor Story

Patient Info: Taylor, Female, Under 40 | Stage I

Taylor had a Stage IB 4 cm lung carcinoid tumor removed surgically with clean margins at age 21. She did not need chemotherapy or radiation and was 18 years post-diagnosis as of February 2026.

The Patient StoryRead more →

Lung Cancer Treated With Sleeve Right Lower Lobectomy in COPD — Case 2

Patient Info: Anonymized, male | Stage I

He remained disease-free through 26 months of follow-up.

PubMed CentralRead more →

Early lung adenocarcinoma found on screening with surgical recovery after tamponade complication

Patient Info: Anonymized, Male, 60s | Stage I

The Stage I lung adenocarcinoma was removed by wedge resection with clear margins. A life-threatening postoperative cardiac tamponade was successfully treated, and the patient was discharged on postoperative day 19 with full recovery.

PubMed CentralRead more →

Stage IA primary mucinous lung adenocarcinoma with enteric differentiation in a patient with CLL/SLL

Patient Info: Anonymized, Male, 70+ | Stage I

Biomarkers: Lung tumor markers supported mucinous adenocarcinoma with enteric features. CLL/SLL markers were present in lymph nodes, not lung metastasis.

As of January 2026, he remained free of lung cancer for 24 months after thoracoscopic wedge resection of localized Stage IA primary mucinous lung adenocarcinoma, while CLL/SLL continued to be managed separately.

PubMed CentralRead more →

Early Stomach Cancer Surgery Followed by a Rare Bowel Complication

Patient Info: Anonymized, Female, 70+ | Stage I

At 6 months after corrective surgery, she remained free of vomiting without symptom recurrence.

PubMed CentralRead more →

Male breast cancer history complicated by suspected bone disease and later IgG-kappa multiple myeloma

Patient Info: Anonymized, Male, 60s | Stage I

Biomarkers: Breast cancer was ER/PR-positive and HER2-negative by FISH. Later workup showed IgG-kappa multiple myeloma with IgH rearrangement.

The patient achieved very good partial response after KBD and completed autologous hematopoietic stem cell transplantation with engraftment, but later died of a novel coronavirus infection.

PubMed CentralRead more →

Stage I HR-Positive Invasive Lobular Carcinoma: Erica's Survivor Story

Patient Info: Erica, Female, 40s | Stage I

Biomarkers: ER-positive; PR-positive; HER2-negative

As of December 2025, Erica had Stage IA ER-positive/PR-positive/HER2-negative ILC removed with negative lymph nodes, completed 16 rounds of radiation, and was focused on survivorship and advocacy.

Lobular Breast Cancer AllianceRead more →

Glycogen-rich clear cell breast carcinoma: HER2-positive early-stage case with disease-free follow-up

Patient Info: Anonymized, Female, 60s | Stage I

Biomarkers: ER-positive; HER2-positive; PR-negative; Ki-67 ~10%; intracytoplasmic glycogen confirmed

At 1-year follow-up, she had no evidence of breast cancer recurrence.

PubMed CentralRead more →

Stage I Immature Ovarian Teratoma With a Benign Teratoma in the Other Ovary

Patient Info: Anonymized, female, Under 40 | Stage I

Biomarkers: AFP 90 ng/mL at diagnosis; CA-125 within normal range

Follow-up imaging showed no recurrence, and she remained well under regular oncologic surveillance after chemotherapy was stopped early.

PubMed CentralRead more →

Stage I AR-positive triple-negative invasive apocrine breast carcinoma: disease-free after surgery, radiotherapy and chemotherapy

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: Triple-negative apocrine breast carcinoma with androgen receptor 90%

At 1-year follow-up, she remained disease-free with no clinical or radiologic evidence of recurrence.

PubMed CentralRead more →

Second primary Stage I lung adenocarcinoma treated with segmentectomy and adjuvant pembrolizumab

Patient Info: Anonymized, Female, 70+ | Stage I

Biomarkers: PD-L1 <1%; no common targetable lung cancer changes found in EGFR, ALK, KRAS, BRAF, MET, PIK3CA, RET, ROS1, or NTRK.

At 6-month oncologic follow-up, PET-CT showed complete metabolic response with no evidence of residual disease after segmentectomy and adjuvant pembrolizumab.

PubMed CentralRead more →

Stage I low rectal adenocarcinoma: ileal J-pouch salvage reconstruction after rectovaginal fistula

Patient Info: Anonymized, Female, 50s | Stage I

Biomarkers: CEA remained within normal range during follow-up; no molecular biomarkers reported

At 5 years after salvage reconstruction, colonoscopy showed no recurrence, stricture, or pouch complication; annual CT showed no local recurrence or distant metastasis; CEA remained normal and bowel function was satisfactory.

PubMed CentralRead more →

Stage I ER-positive PR-negative breast cancer: disease-free after lumpectomy, radiation and tamoxifen

Patient Info: Anonymized, Female, 40s | Stage I

Biomarkers: ER 2+ in 60% of tumor cells; PR-negative; HER2/neu-negative; Ki-67 5%; 0/6 lymph nodes positive

At 15 months after surgery, she was disease-free, had no complaints, and was satisfied with the surgical result.

PubMed CentralRead more →

Stage I Invasive Lobular Carcinoma: Tammy's Survivor Story

Patient Info: Tammy, Female, 60s | Stage I

As of October 2025, Tammy had fully recovered and remained disease-free after Stage I invasive lobular breast cancer treated with partial mastectomy and a targeted week-long radiation course, with ongoing follow-up monitoring.

Cleveland ClinicRead more →

Stage I Colorectal Cancer: Jessica's Survivor Story

Patient Info: Jessica, Female, Under 40 | Stage I

Biomarkers: Lynch syndrome

Jessica had Stage I Lynch syndrome-associated rectal cancer treated with an immunotherapy clinical-trial approach rather than chemoradiation or surgery. Midpoint colonoscopy and MRI showed the mass was gone, and she completed 7 infusions over 6 months. As of September 2025, she was in survivorship with intensive Lynch syndrome surveillance.

The Patient StoryRead more →

Stage I Breast Cancer: Angela's Patient Story

Patient Info: Angela George, Female, 40s | Stage I

Biomarkers: Not explicitly reported; Herceptin was given

As of September 2025, Angela was approaching 5 years from her Stage I breast cancer diagnosis, had completed bilateral mastectomy, chemotherapy, Herceptin, and oophorectomy, and remained on daily estrogen-reducing medication with oncology visits every 6 months; the source does not explicitly state NED.

Cleveland ClinicRead more →